Tracheal Stenosis Clinical Trial
tracheal stenosis is the result of abnormal wound-healing processes leading to hypertrophic scar formation and obstruction of the airway lumen by excess granulation tissue. This process is progressive so treatment and prevention is essential. Resection-anastomosis of the trachea is becoming the standard of care in many centers and gives the most consistent results in both adult and pediatric patients. But recurrence stenosis, re-granulation and re-inflammation are probable. This study aimed to assess the efficacy of systemic prednisolone on prevention of recurrent tracheal stenosis after surgery.
Tracheal stenosis affects 4-13% of adults and occurs in 1-8% of neonates after prolonged
intubation in United States. The causes of adults' tracheal stenosis include trauma, chronic
inflammatory diseases, benign neoplasm, malignant neoplasm and collagen vascular diseases.
The most common cause of tracheal stenosis continues to be trauma, which can be internal
(prolonged endotracheal intubation, tracheostomy, flame, burn injury) or external (neck
trauma). Approximately 90% of chronic subglottic stenosis in children and adults results
from endotracheal intubation or tracheostomy and about 10% results from other causes.
The resection anastomosis is the most effective treatment to cure this condition. The other
treatments are mechanical dilation (dilators, rigid bronchoscopes), stents, laser co2,
diode, and cold knife. But they are not as effective as resection anastomosis. Rigid
bronchoscopes or dilators may shear the mucosa leading to further damage. Resection of all
damaged segments of the airway, approximation and anastomosis of the two intact ends by
means of fine synthetic absorbable sutures with minimum tension. Steroids with
anti-inflammatory effect widely use as first line therapy for this condition.
Patients who underwent resection anastomosis during 2014-2016 for treatment of
post-intubation tracheal stenosis will be included in this study. Systemic prednisolone will
be used for treatment and prevention of recurrent tracheal stenosis in post-operative
patients. Post-operative patients will divide in two groups, one of them will receive
prednisolone and the other will receive placebo for 30 days. The results will be compared by
bronchoscopy (FOB or rigid) after 30 days.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT02949414 -
A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells
|
Phase 1 | |
Not yet recruiting |
NCT03411928 -
Endotracheal Dilator to Improve Oxygenation
|
N/A | |
Recruiting |
NCT05028023 -
Tracheal Dilatation in Pediatric Patients With Acquired Tracheal Stenosis, and the Effects of Apneic Oxygenation
|
N/A | |
Completed |
NCT02796326 -
Modified Endotracheal Balloon Dilator to Improve Patient Oxygenation and Allow Ventilation During Airway Procedures
|
N/A | |
Completed |
NCT06121024 -
Long-term Outcomes of Post-intubation Tracheal Stenosis; 7-year Follow-up
|
||
Recruiting |
NCT02961387 -
A Clinical Trial on Effectiveness and Safety of Hydrogen Generator to Treat Dyspnea for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study
|
N/A | |
Completed |
NCT04674995 -
Stent Versus Balloon Dilatation in Patients With Tracheal Benign Stenosis
|
||
Completed |
NCT01331863 -
Airway and/or Pulmonary Vessels Transplantation
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05835713 -
Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam
|
N/A | |
Suspended |
NCT02620319 -
Biodegradable Stents in the Management of Stenoses of the Large Airways
|
N/A | |
Recruiting |
NCT03455881 -
Phenotypic and Genetic Assessment of Tracheal and Esophageal Birth Defects in Patients
|
||
Recruiting |
NCT04719845 -
DilAtation Versus Endoscopic Laser Resection in Simple Benign trAcheal sTEnosis
|
N/A | |
Completed |
NCT05317923 -
Airway Management During Unusual Tracheal Stenosis
|
N/A | |
Enrolling by invitation |
NCT05535803 -
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
|
Phase 2 | |
Completed |
NCT00705848 -
Matrix Biology of Tracheobronchomalacia and Tracheal Stenosis
|
N/A | |
Completed |
NCT03130374 -
Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells
|
Phase 1/Phase 2 | |
Completed |
NCT06061380 -
Challenges and Management of Post-intubation Tracheal Stenosis
|
||
Not yet recruiting |
NCT04625400 -
Role of Bronchoscopy in Assessment of Patients With Post-intubation Tracheal Stenosis
|
N/A | |
Enrolling by invitation |
NCT04850742 -
Feasibility of Tracheobronchial Reconstruction Using Bioengineered Aortic Matrices
|
N/A | |
Completed |
NCT05682651 -
Relationship Between Post-Intubation Tracheal Stenosis and Covid-19
|